BBNX Beta Bionics, Inc.
18.08USD-2.95%Mkt Cap: 975.35M $P/E: —1d ago
Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. I…
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap975.35M USD
Enterprise Value664.18M USD
Revenue (TTM)119.01M USD
Gross Profit55.54M USD
Net Income (TTM)-73.20M USD
Revenue/Share2.69 USD
Last Price18.08 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees420
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-8.01
PEG—
EV/EBITDA-8.22
EV/Revenue5.58
P/S8.44
P/B3.27
EPS (TTM)-1.64
EPS (Forward)-2.33
52W Range
8.80039% of range32.71
52W High32.71 USD
52W Low8.800 USD
Profitability
Gross Margin55.40%
Oper. Margin-79.90%
EBITDA Margin-67.89%
Profit Margin-73.02%
ROE-25.45%
ROA-22.27%
Growth
Revenue Growth37.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-50.92M USD
CapEx (TTM)5.30M USD
FCF Margin-33.86%
FCF Yield-4.13%
Net Debt-173.98M USD
Net Debt/EBITDA2.15
Balance Sheet
Debt/Equity0.03
Current Ratio8.88
Quick Ratio7.72
Book Value/Sh5.70 USD
Cash/Share4.01 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.7 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)23.28 USD
Upside (mean)+28.8%
Target Range16.00 USD – 30.40 USD
16.00+28.8% to mean30.40
# Analysts12
Ownership
Shares Out.53.95M
Float31.16M
Insiders0.82%
Institutions95.87%
Short Interest
Short Ratio9.8d
Short % Float23.71%
Short % Out.23.60%
Shares Short10.62M
Short (prev mo.)7.49M
Technical
SMA 5018.42 (-1.8%)
SMA 20015.77 (+14.7%)
Beta—
S&P 52W Chg16.45%
Avg Vol (30d)1.48M
Avg Vol (10d)1.06M
Technical Indicators
RSI (14)40.9
MACD-0.0416
MACD Signal0.3759
MACD Hist.-0.4175
BB Upper23.91 USD
BB Middle19.87 USD
BB Lower15.82 USD
BB Width40.69%
ATR (14)1.322 USD
Vol Ratio (20d)0.86x